Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling

Journal of Drug Delivery Science and Technology

Volumn 19, Issue 2, 2009, Pages 75-88

  Delgado Charro, M B ^a  

^a University of Bath   (United Kingdom)

Author keywords

Drug delivery; Electromigration; Electroosmosis; Lontophoresis; Non invasive; Reverse iontophoresis; Topical; Transdermal

Indexed keywords

ACETIC ACID; ACICLOVIR; ADRENALIN; AMINOLEVULINIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; CYCLOSPORIN A; DEFEROXAMINE; DEXAMETHASONE SODIUM PHOSPHATE; DICLOFENAC; EMLA; ETOFENAMATE; FENTANYL; IBUPROFEN LYSINE; IONTOCAINE; KETOPROFEN; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE DERIVATIVE; PLACEBO; PROTEIN DERIVATIVE; ROTIGOTINE; SALCATONIN; SALICYLATE SODIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZOLMITRIPTAN;

ADVISORY COMMITTEE; AREA UNDER THE CURVE; BOLUS INJECTION; BOWEN DISEASE; CALCINOSIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TRANSPORT; ELECTROOSMOSIS; GLUCOSE BLOOD LEVEL; HERPES LABIALIS; HUMAN; IONTOPHORESIS; LOCAL ANESTHESIA; LOW BACK PAIN; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; MIGRAINE; NON INVASIVE PROCEDURE; NONHUMAN; PAIN; PARKINSON DISEASE; PATIENT COMPLIANCE; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PLANTAR FASCIITIS; POSTOPERATIVE PAIN; PROCESS OPTIMIZATION; PSORIASIS; REVIEW; SKIN CANCER; SOFT TISSUE INFLAMMATION; SYNOVITIS; TENDINITIS; TENNIS ELBOW; TOPICAL ANESTHESIA; VERRUCA PLANTARIS; VIRUS INFECTION;

EID: 63649107817     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(09)50015-9     Document Type: Review

References (220)

1. Scott E.R., Phipps P.J. Gyory R., Padmanabhan R.V.- Electrotransport systems for transdermal delivery: a practical implementation of iontophoresis.- Handbook of Pharmaceutical Controlled Release Technology, Wise D.L. Ed., Marcel Dekker, New York, 2000, pp. 617-659.
2. Subramony J.A., Sharma A., Phipps J.B.- Microprocessor controlled transdermal drug delivery.- Int J Pharm, 317, 1-6, 2006.
3. Kalia Y.N., Naik A., Garrison J., Guy R.H.- Iontophoretic drug delivery.- Adv Drug Deliv Rev, 56, 619-658, 2004.
4. Leboulanger B., Guy R.H., Delgado-Charro M.B.- Reverse iontophoresis for non-invasive transdermal monitoring.- Physiol Meas, 25, R35-50, 2004.
5. Mudry B.G., Guy R.H., Delgado-Charro M.B.- Iontophoresis in transdermal delivery.- In: Enhancement in Drug Delivery, Touitou E. and Barry B.W. Eds., CRC Press, Boca Raton, 2006, pp. 279-302.
6. Delgado-Charro M.B., Guy R.H.- Transdermal iontophoresis for drug delivery and non-invasive monitoring.- STP Pharma. Sciences, 11, 403-414, 2001.
7. Nirschl R.P., Rodin D.M., Ochiai D.H., Maartmann-Moe C.- Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis. A randomized, double-blinded, placebo-controlled study. -Am J Sports Med, 31, 189-195, 2003.
8. Anderson C.R., Morris R.L., Boeh S.D., Panus P.C., Sembrowich W.L. - Effects of iontophoresis current magnitude and duration on dexamethasone deposition and localized drug retention. - Phys Ther, 83, 161-170, 2003.
9. Nowicki K.D., Hummer C.D., 3rd, Heidt R.S., Jr., Colosimo A.J. - Effects of iontophoretic versus injection administration of dexamethasone.- Med Sci Sports Exerc, 34, 1294-1301, 2002.
10. Gurney B., Wascher D., Eaton L., Benesh E., Lucak J.-The effect of skin thickness and time in the absorption of dexamethasone in human tendons using iontophoresis.- J Orthop Sports Phys Ther, 38, 238-245, 2008.
11. Gurney A.B., Wascher D.C.- Absorption of dexamethasone sodium phosphate in human connective tissue using iontophoresis. - Am J Sports Med, 36, 753-759, 2008.
12. Sylvestre J.P., Guy R.H., Delgado-Charro M.B.- In vitro optimization of dexamethasone phosphate delivery by iontophoresis. - Phys Ther, 88, 1177-1185, 2008.
13. Sylvestre J.P., Diaz-Marin C., Delgado-Charro M.B., Guy R.H. - Iontophoresis of dexamethasone phosphate: competition with chloride ions.- J Control Release, 131, 41-46, 2008.
14. Bender T., Bariska J., Rojkovich B., Balint G.- Etofenamate levels in human serum and synovial fluid following iontophoresis. - Arzneimittelforschung, 51, 469-492, 2001.
15. Tashiro Y., Kato Y., Hayakawa E., Ito K.- Iontophoretic transdermal delivery of ketoprofen: novel method for the evaluation of plasma drug concentration in cutaneous vein.- Biol Pharm Bull, 23, 632-636, 2000.
16. Tashiro Y., Kato Y., Hayakawa E., Ito K.- Iontophoretic transdermal delivery of ketoprofen: effect of iontophoresis on drug transfer from skin to cutaneous blood.- Biol Pharm Bull, 23, 1486-1490, 2000.
17. Curdy C., Kalia Y. N., Naik A., Guy R.H.- Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion.- J Control Release, 76, 73-79, 2001.
18. Herkenne C., Alberti I., Naik A., Kalia Y. N., Mathy RX., Preat V., Guy R.H.- In vivo methods for the assessment of topical drug bioavailability.- Pharm Res, 25, 87-103, 2008.
19. Doliwa A., Santoyo S., Ygartua P.- Transdermal Iontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.- Drug Dev Ind Pharm, 27, 751-758, 2001.
20. Lambrecht R., Clarys P., Clijsen R., Barel A.O.- Determination of the in vivo bioavailability of iontophoretically delivered diclofenac using a methyl nicotinate skin inflammation assay.- Skin Res Technol, 12, 211-216, 2006.
21. Santi P., Nicoli S., Colombo G., Bettini R., Artusi M., Rimondi S., Padula C., Rizzo P., Colombo P.- Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin.- Int J Pharm, 266, 69-75, 2003.
22. Shetty S., Moore T.L., Jackson S., Brettle D., Herrick A.L.- A pilot study of acetic acid iontophoresis and ultrasound in the treatment of systemic sclerosis-related calcinosis.- Rheumatology, 44, 536-538, 2005.
23. Ciccone C.D.- Does acetic acid iontophoresis accelerate the resorption of calcium deposits in calcifying tendinitis of the shoulder?- Phys Ther, 83, 68-74, 2003.
24. Leduc B.E., Caya J., Tremblay S., Bureau N.J., Dumont M. - Treatment of calcifying tendinitis of the shoulder by acetic acid iontophoresis: a double-blind randomized controlled trial.- Arch Phys Med Rehabil, 84, 1523-1527, 2003.
25. Costa I.A., Dyson A.-The integration of acetic acid iontophoresis, orthotic therapy and physical rehabilitation for chronic plantar fasciitis: a case study.- JCCA J Can Chiropr Assoc, 51, 166-174, 2007.
26. Galinkin J.L., Rose J.B., Harris K., Watcha M.R- Lidocaine iontophoresis versus eutectic mixture of local anesthetics (EMLA) for IV placement in children.- Anesth Analg, 94, 1484-1488, 2002.
27. Squire S.J., Kirchhoff K.T., Hissong K.- Comparing two methods of topical anesthesia used before intravenous cannulation in pediatric patients.- J Pediatr Health Care, 14, 68-72, 2000.
28. Rose J.B., Galinkin J.L., Jantzen E.C., Chiavacci R.M.- A study of lidocaine iontophoresis for pediatric venipuncture.- Anesth Analg, 94, 867-871,2002.
29. Moppett I.K., Szypula K., Yeoman P.M.- Comparison of EMLA and lidocaine iontophoresis for cannulation analgesia.- Eur J Anaesthesiol, 21, 210-213, 2004.
30. Zempsky W.T., Parkinson T.M.- Lidocaine iontophoresis for local anesthesia before shave biopsy.- Dermatol Surg, 29, 627-630, 2003.
31. Kearns G.L., Heacook J., Daly S.J., Singh H., Alander S.W., Qu S.- Percutaneous lidocaine administration via a new iontophoresis system in children: tolerability and absence of systemic bioavailability.- Pediatrics, 112, 578-582, 2003.
32. Tokmakci M., Ekmekcioglu O., Alci M.- A programmable iontophoretic instrument and its application for local anesthesia before surgery in urology.- J Med Syst, 29, 197-204, 2005.
33. Yarrobino T.E., Kalbfleisch J.H., Ferslew K.E., Panus P.C.- Lidocaine iontophoresis mediates analgesia in lateral epicondylalgia treatment.- Physiother Res Int, 11, 152-160, 2006.
34. Holovics H.J., Anderson C.R., Levine B.S., Hui H.W., Lunte C. E. - Investigation of drug delivery by iontophoresis in a surgical wound utilizing microdialysis.- Pharm Res, 2007.
35. Meyer P.F., Oddsson L.I.- Alternating-pulse iontophoresis for targeted cutaneous anesthesia.- J Neurosci Methods, 125, 209-214, 2003.
36. Wallace M.S., Ridgeway B., Jun E., Schulteis G., Rabussay D., Zhang L. Topical delivery of lidocaine in healthy volunteers by electroporation, electroincorporation, or iontophoresis: an evaluation of skin anesthesia.- Reg Anesth Pain Med, 26, 229-238, 2001.
37. Soroko Y.T., Repking M.C., Clemment J.A., Mitchell P.L., Berg L. - Treatment of plantar verrucae using 2% sodium salicylate iontophoresis.- Phys Ther, 82, 1184-1191, 2002.
38. Stagni G., Ali M.E., Weng D.- Pharmacokinetics of acyclovir in rabbit skin after i.v. -bolus, ointment, iontophoretic administrations. - Int J Pharm, 274, 201-211, 2004.
39. Padula C., Sartori F., Marra F., Santi P.- The influence of iontophoresis on acydovir transport and accumulation in rabbit ear skin.- Pharm Res, 22, 1519-1524, 2005.
40. Morrel E.M., Spruance S.L., Goldberg D.I.- Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.- Clin Infect Dis, 43, 460-467, 2006.
41. Pharmaceuticals T.- SolovirTM for Herpes Labialis Fact Sheet. - http://www.transportpharma.com/content/technology/solovir.jsp
42. Abla N., Naik A., Guy R.H., Kalia Y.N.- Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. - Pharm Res, 23, 1842-1849, 2006.
43. Tiwari S.B., Kumar B.C., Udupa N., Balachandran C.- Topical methotrexate delivered by iontophoresis in the treatment of recalcitrant psoriais- a case report.- Int J Dermatol, 42, 157-159, 2003.
44. Alvarez-Figueroa M.J., Delgado-Charro M.B., Blanco-Mendez J. - Passive and iontophoretic transdermal penetration of methotrexate. - Int J Pharm, 212, 101-107, 2001.
45. Alvarez-Figueroa M.J., Blanco-Mendez J.- Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions.- Int J Pharm, 215, 57-65, 2001.
46. Stagni G., Shukla C.- Pharmacokinetics of methotrexate in rabbit skin and plasma after iv-bolus and iontophoretic administrations. - J Control Release, 93, 283-292, 2003.
47. Boinpally R.R., Zhou S.L., Devraj G., Anne P.K., Poondru S., Jasti B.R.- Iontophoresis of lecithin vesicles of cyclosporin A. - Int J Pharm, 274, 185-190, 2004.
48. Star W.M., Aalders M.C., Sac A., Sterenborg H.J.- Quantitative model calculation of the time-dependent protoporphyrin IX concentration in normal human epidermis after delivery of ALA by passive topical application or Iontophoresis.- Photochem Photobiol, 75, 424-432, 2002.
49. Gerscher S., Connelly J.P., Beijersbergen Van Henegouwen G.M., MacRobert A.J., Watt P., Rhodes L.E.- A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester. - Br J Dermatol, 144, 983-990, 2001.
50. Gerscher S., Connelly J.P., Griffiths J., Brown S.B., MacRobert A.J., Wong G., Rhodes L.E.- Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. - Photochem Photobiol, 72, 569-574, 2000.
51. Lopez R.F., Bentley M.V., Begona Delgado-Charro M., Guy R.H. - Optimization of aminolevulinic acid delivery by iontophoresis. - J Control Release, 88, 65-70, 2003.
52. Lopez R.F., Bentley M.V., Delgado-Charro M.B., Guy R.H. - Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH.- Pharm Res, 18, 311-315, 2001.
53. Lopez R.F., Bentley M.V., Delgado-Charro M.B., Salomon D., van den Bergh H., Lange N., Guy R.H.- Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro.- Photochem Photobiol, 77, 304-308, 2003.
54. Bodde H.E., Roemele P.E., Star W.M.- Quantification of topically delivered 5-aminolevulinic acid by Iontophoresis across ex vivo human stratum corneum.- Photochem Photobiol, 75, 418-423, 2002.
55. Choudry K., Brooke R.C., Farrar W., Rhodes L.E.- The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.- Br J Dermatol, 149, 124-130, 2003.
56. Merclin N., Bender J., Sparr E., Guy R.H., Ehrsson H., Engstrom S. - Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester.- J Control Release, 100, 191-198, 2004.
57. Merclin N., Bramer T., Edsman K.- Iontophoretic delivery of 5-aminolevulinic acid and its methyl ester using a carbopol gel as vehicle.- J Control Release, 98, 57-65, 2004.
58. Gelfuso G.M., Figueiredo F.V., Gratieri T., Lopez R.F.- The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS(4)).- J Pharm Sci, 2008.
59. Ebihara M., Akiyama M., Ohnishi Y., Tajima S., Komata K., Mitsui Y.- Iontophoresis promotes percutaneous absorption of L-ascorbic acid in rat skin.- J Dermatol Sci, 32, 217-222, 2003.
60. Ueda T W., Y, Akao K Suzuki H- Nononvasive detection by ATR and NDR-DR methods for skin care ionic materials transported into the skin by iontophoresis.- J Mol Struct, 661-662, 391-392, 2003.
61. Brasch J., Huttemann M., Proksch E.- Iontophoresis of nickel elicits a delayed cutaneous response in sensitized individuals that is similar to an allergic patch test reaction.- Contact Dermatitis, 42, 36-41,2000.
62. Herndon C.M.- Iontophoretic drug delivery system: focus on fentanyl.- Pharmacotherapy, 27, 745-754, 2007.
63. Viscusi E.R.- Patient-controlled drug delivery for acute post-operative pain management: a review of current and emerging technologies.- Reg Anesth Pain Med, 33, 146-158, 2008.
64. Ahmad S., Hewitt D.J., Damaraju C.V.- Fentanyl HCI iontophoretic transdermal system versus intravenous morphine pump after gynecologic surgery.- Arch Gynecol Obstet, 276, 251-258, 2007.
65. Power I.- Fentanyl HCI iontophoretic transdermal system (ITS): clinical application of iontophoretic technology in the management of acute postoperative pain.- Br J Anaesth, 98, 4-11, 2007.
66. Jansen-Cilag Ltd- Package leaflet. IONSYS 40 micrograms per dose iontophoretic transdermal system fentanyl. - http://emc.medicines.org.uk/ eme/assets/c/html/DisplayDoc.asp?DocumentlD=20459, 2008.
67. Sinatra R.- The fentanyl HCI patient-controlled transdermal system (PCTS): an alternative to intravenous patient-controlled analgesia in the postoperative setting.- Clin Pharmacokinet, 44, Suppl 1, 1-6, 2005.
68. Gupta S.K., Hwang S., Southam M., Sathyan G.- Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCI patient-controlled transdermal system (PCTS).- Clin Pharmacokinet, 44, Suppl 1, 25-32, 2005.
69. Sathyan G., Jaskowiak J., Evashenk M., Gupta S.- Characterisation of the pharmacokinetics of the fentanyl HCI patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing and comparison with IV fentanyl administration. - Clin Pharmacokinet, 44, Suppl 1, 7-15, 2005.
70. Sathyan G., Zomorodi K., Gidwani S., Gupta S.- The effect of dosing frequency on the pharmacokinetics of a fentanyl HCI patient-controlled transdermal system (PCTS).- Clin Pharmacokinet, 44, Suppl 1, 17-24, 2005.
71. Hartrick C.T., Bourne M.H., Gargiulo K., Damaraju C.V., Vallow S., Hewitt D.J.- Fentanyl iontophoretic transdermal system for acute-pain management after orthopedic surgery:a comparative study with morphine intravenous patient-controlled analgesia. - Reg Anesth Pain Med, 31, 546-554, 2006.
72. Mayes S., Ferrone M.- Fentanyl HCI patient-controlled iontophoretic transdermal system for the management of acute post-operative pain.- Ann Pharmacother, 40, 2178-2186, 2006.
73. Viscusi E.R., Reynolds L., Chung F., Atkinson L.E., Khanna S. - Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial.- JAMA, 291, 1333-1341, 2004.
74. Minkowitz H.S., Rathmell J.P., Vallow S., Gargiulo K., Damaraju C.V., Hewitt D.J.- Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery.- Pain Med, 8, 657-668, 2007.
75. Viscusi E.R., Reynolds L., Tait S., Melson T., Atkinson L.E.- An iontophoretic fentanyl patient-activated analgesic delivery system for postoperative pain: a double-blind, placebo-controlled trial.- Anesth Analg, 102, 188-194, 2006.
76. Chaturvedula A., Joshi D.P., Anderson C., Morris R.L., Sembrowich W.L., Banga A.K.- In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin.- Int J Pharm, 297, 190-196, 2005.
77. Inc. T.R- IontoPatch device(R). Iontophoresis with the Battery Built in.- http://www.travantipharma.com/markets_iontopatchdevice.html
78. Nakamura K., Katagai K., Mori K., Higo N., Sato S., Yamamoto K. - Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats.- Int J Pharm, 218, 93-102, 2001.
79. Nicoli S., Rimondi S., Colombo P., Santi P.- Physical and chemical enhancement of transdermal delivery of triptorelin.- Pharm Res, 18, 1634-1637, 2001.
80. Nicoli S., Santi P., Couvreur P., Couarraze G., Colombo P., Fattal E. - Design of triptorelin loaded nanospheres for transdermal iontophoretic administration.- Int J Pharm, 214, 31-35, 2001.
81. Schuetz Y. B., Naik A., Guy R.H., Vuaridel E., Kalia Y. N.-Transdermal iontophoretic delivery of triptorelin in vitro.- J Pharm Sci, 94, 2175-2182, 2005.
82. Kochhar C., Imanidis G.- In vitro transdermal iontophoretic delivery of leuprolide under constant current application.- J Control Release, 98, 25-35, 2004.
83. Kochhar C., Imanidis G.- In vitro transdermal iontophoretic delivery of leuprolide-mechanisms under constant voltage application. - J Pharm Sci, 92, 84-96, 2003.
84. Rastogi S.K., Singh J.- Lipid extraction and iontophoretic transport of leuprolide acetate through porcine epidermis.- Int J Pharm, 215, 241-249, 2001.
85. Delgado-Charro M.B. and Guy. R.H.- Iontophoretic delivery of nafarelin across the skin.- Int. J. Pharm, 117, 165-172, 1995.
86. Raiman J., Koljonen M., Huikko K., Kostiainen R., Hirvonen J. - Delivery and stability of LHRH and Nafarelin in human skin: the effect of constant/pulsed iontophoresis.- Eur J Pharm Sci, 21, 371-377, 2004.
87. Meyer B.R., Kreis W., Eschbach J., O'Mara V., Rosen S., Sibalis D. - Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers.- Clin Pharmacol Ther, 44, 607-612, 1988.
88. Vyteris Inc.- Vyteris announces successful completion of peptide dose ranging study in preparation for phase II human clinical trials.- http://investor.vyteris.com/releasedetail.cfm?ReleaseID=324576,
89. Schuetz Y. B., Naik A., Guy R.H., Vuaridel E., Kalia Y. N.-Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro.- Pharm Res, 22, 1305-1312, 2005.
90. Altenbach M., Schnyder N., Zimmermann C., Imanidis G.- Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.- Int J Pharm, 307, 308-317, 2006.
91. Abla N., Naik A., Guy R.H., Kalia Y.N.- Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis. - Pharm Res, 22, 2069-2078, 2005.
92. Nair V., Panchagnula R.- Poloxamer gel as vehicle for transdermal iontophoretic delivery of arginine vasopressin: evaluation of in vivo performance in rats.- Pharmacol Res, 47, 555-562, 2003.
93. Nair V.B., Panchagnula R.- Effect of iontophoresis and fatty acids on permeation of arginine vasopressin through rat skin. - Pharmacol Res, 47, 563-569, 2003.
94. Nair V., Panchagnula R.- Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide.- Pharmacol Res, 48, 175-182, 2003.
95. Nair V.B., Panchagnula R.- Influence of electrical parameters in the iontophoretic delivery of a small peptide: in vitro studies using arginine-vasopressin as a model peptide.- Farmaco, 59, 583-593, 2004.
96. Suzuki Y., Iga K., Yanai S., Matsumoto Y., Kawase M., Fukuda T., Adachi H., Higo N., Ogawa Y.- Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34).- J Pharm Pharmacol, 53, 1227-1234, 2001.
97. Suzuki Y., Nagase Y., Iga K., Kawase M., Oka M., Yanai S., Matsumoto Y., Nakagawa S., Fukuda T., Adachi H., Higo N., Ogawa Y.- Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34).- J Pharm Sci, 91, 350-361,2002.
98. Cazares-Delgadillo J., Naik A., Ganem-Rondero A., Quintanar-Guerrero D., Kalia Y.N.- Transdermal delivery of cytochrome C-A 12.4 kDa protein-across intact skin by constant-current iontophoresis.- Pharm Res, 24, 1360-1368, 2007.
99. Kavanagh G.M., Oh C., Shams K.- BOTOX delivery by iontophoresis. - Br J Dermatol, 151, 1093-1095, 2004.
100. Kavanagh G.M., Shams K.- Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis.- J Am Acad Dermatol, 55, S115-117, 2006.
101. Devarian S.- A comment on "Kavanagh M, Shams K. Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis". - J Am Acad Dermatol, 58, 2008.
102. Pacini S., Gulisano M., Punzi T., Ruggiero M.- Transdermal delivery of Clostridium botulinum toxin type A by pulsed current iontophoresis.- J Am Acad Dermatol, 57, 1097-1099, 2007.
103. Lim E.C., Seet R.C., Chow A., Oh V.M., Ong B.K., Wilder-Smith E.P.- Topical botulinum toxin to treat hyperhidrosis? No sweat!-Med Hypotheses, 67, 27-32, 2006.
104. Abla N., Naik A., Guy R.H., Kalia Y.N.- Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.- J Control Release, 108, 319-330, 2005.
105. Kim A., Green P.G., Rao G., Guy R.H.- Convective solvent flow across the skin during iontophoresis.- Pharm Res, 10, 1315-1320, 1993.
106. Uitto O.D., White H.S.- Electroosmotic pore transport in human skin.- Pharm Res, 20, 646-652, 2003.
107. Schuetz Y.B., Naik A., Guy R.H., Kalia Y.N.- Effect of amino acid sequence on transdermal iontophoretic peptide delivery.- Eur J Pharm Sci, 26, 429-437, 2005.
108. Schuetz Y.B., Carrupt P.A., Naik A., Guy R.H., Kalia Y. N.- Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis.- Eur J Pharm Sci, 29, 53-59, 2006.
109. Steiger M.- Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease.- Eur J Neurol, 15, 6-15, 2008.
110. Kankkunen T., Huupponen I., Lahtinen K., Sundell M., Ekman K., Kontturi K., Hirvonen J.- Improved stability and release control of levodopa and metaraminol using ion-exchange fibers and transdermal iontophoresis.- Eur J Pharm Sci, 16, 273-280, 2002.
111. Compendium E.M.- Requip tablets, SPC from the eMC. - http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID= 2056
112. Luzardo-Alvarez A., Delgado-Charro M.B., Blanco-Mendez J. - Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation.- Pharm Res, 18, 1714-1720, 2001.
113. Luzardo-Alvarez A., Delgado-Charro M.B., Blanco-Mendez J.- In vivo iontophoretic administration of ropinirole hydrochloride.- J Pharm Sci, 92, 2441-2448, 2003.
114. Li G.L., Danhof M., Bouwstra J.A.- Lontophoretic delivery of apomorphine in vitro: physicochemic considerations.- Pharm Res, 18, 1509-1513, 2001.
115. Li G.L., Grossklaus A., Danhof M., Bouwstra J.A.- Iontophoretic R-apomorphine delivery in combination with surfactant pre-treatment: in vitro validation studies.- Int J Pharm, 266, 61-68, 2003.
116. Li G.L., van der Geest R., Chanet L., van Zanten E., Danhof M., Bouwstra J.A.- In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement.- J Control Release, 84, 49-57, 2002.
117. Li G.L., Danhof M., Frederik RM., Bouwstra J.A.- Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro.- Pharm Res, 20, 653-659, 2003.
118. Li G.L., Danhof M., Bouwstra J.A.- Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro.- Pharm Res, 18, 1627-1630, 2001.
119. de Graaff A.M., Li G.L., van Aelst A.C., Bouwstra J.A.- Combined chemical and electrical enhancement modulates stratum corneum structure.- J Control Release, 90, 49-58, 2003.
120. Li G.L., de Vries J.J., van Steeg T.J., van den Bussche H., Maas H.J., Reeuwijk H.J., Danhof M., Bouwstra J.A., van Laar T. - Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment.- J Control Release, 101, 199-208, 2005.
121. Nugroho A.K., Li G., Grossklaus A., Danhof M., Bouwstra J.A. -Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro.- J Control Release, 96, 159-167, 2004.
122. Nugroho A.K., Li G.L., Danhof M., Bouwstra J.A. -Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCI concentration.- Pharm Res, 21, 844-850, 2004.
123. Nugroho A.K., Li L., Dijkstra D., Wikstrom H., Danhof M., Bouwstra J.A. - Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.- J Control Release, 103, 393-403, 2005.
124. Nugroho A.K., Della Pasqua O., Danhof M., Bouwstra J.A. - Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.- Pharm Res, 21, 1974-1984, 2004.
125. Nugroho A.K., Della-Pasqua O., Danhof M., Bouwstra J.A. - Compartmental modeling of transdermal iontophoretic transport II: in vivo model derivation and application.- Pharm Res, 22, 335-346, 2005.
126. Nugroho A.K., Romeijn S.G., Zwier R., de Vries J.B., Dijkstra D., Wikstrom H., Della-Pasqua O., Danhof M., Bouwstra J.A. - Pharmacokinetics and pharmacodynamics analysis of transdermal iontophoresis of 5-OH-DPAT in rats: in vitro-in vivo correlation.- J Pharm Sci, 95, 1570-1585, 2006.
127. Femenia-Font A., Balaguer-Fernandez C., Merino V., Lopez-Castellano A. - Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength.- J Pharm Sci, 94, 2183-2186, 2005.
128. Patel S.R., Zhong H., Sharma A., Kalia Y.N.- In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.- Eur J Pharm Biopharm, 66, 296-301, 2007.
129. Siegel S.J., O'Neill C., Dube L.M., Kaldeway P., Morris R., Jackson D., Sebree T.- A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.- Pharm Res, 24, 1919-1926, 2007.
130. Neuroscience N.N.P.i.- NuPathe reports positive phase I results for NP101, a novel transdermal patch for acute migraine- http://www.nupathe.com/press_detail.php?code=16
131. Patel S.R., Zhong H., Sharma A., Kalia Y.N.- Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo.- Eur J Pharm Biopharm, 2008.
132. Vyteris- Pipeline.- http://www.vyteris.com/home/Our Products/ Pipeline.php
133. Sung K.C., Fang J.Y., Hu O.Y.- Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis.- J Control Release, 67, 1-8, 2000.
134. Alvarez-Figueroa M.J., Araya-Silva I., Diaz-Tobar C.- Iontophoretic transdermal delivery of haloperidol.- Pharm Dev Technol, 11, 371-375, 2006.
135. Meidan V.M., Al-Khalili M., Michniak B.B.- Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.- Int J Pharm, 264, 73-83, 2003.
136. Al-Khalili M., Meidan V.M., Michniak B.B.- Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.- AAPS Pharm Sci, 5, E14, 2003.
137. Bose S., Ravis W.R., Lin Y.J., Zhang L., Hofmann G.A., Banga A.K. - Electrically-assisted transdermal delivery of buprenorphine. - J Control Release, 73, 197-203, 2001.
138. Fang J.Y., Sung K.C., Wang J.J., Chu C.C., Chen K.T.- The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.- J Pharm Pharmacol, 54, 1329-1337, 2002.
139. Drummond P.D., de Silva-Rossdeutscher E.- Transcutaneous iontophoresis of methadone provokes local flushing and thermal hyperalgesia.- Inflamm Res, 52, 366-371, 2003.
140. Merino V., Mico-Albinana T., Nacher A., Diez-Sales O., Herraez M., Merino-Sanjuan M.- Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.- J Pharm Pharmacol, 60, 415-420, 2008.
141. Kotwal V., Bhise K., Thube R.- Enhancement of iontophoretic transport of diphenhydramine hydrochloride thermosensitive gel by optimization of pH, polymer concentration, electrode design, pulse rate.- AAPS PharmSciTech, 8, E120, 2007.
142. Chandrashekar N.S., Shobha Rani R.H.- Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.- J Buon, 12, 529-534, 2007.
143. Bacro T.R., Holladay E.B., Stith M.J., Maize J.C., Smith C.M. - Iontophoresis treatment of basal cell carcinoma with cisplatin: a case report.- Cancer Detect Prev, 24, 610-619, 2000.
144. Badkar A.V., Banga A.K.- Electrically enhanced transdermal delivery of a macromolecule.- J Pharm Pharmacol, 54, 907-912, 2002.
145. Pacini S., Punzi T., Gulisano M., Ruggiero M.- Pulsed current iontophoresis of hyaluronic acid in living rat skin.- J Dermatol Sci, 44, 169-171, 2006.
146. Kankkunen T., Sulkava R., Vuorio M., Kontturi K., Hirvonen J. - Transdermal iontophoresis of tacrine in vivo.- Pharm Res, 19, 704-707, 2002.
147. Upasani R.S., Banga A.K.- Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride. - Pharm Res, 21, 2293-2299, 2004.
148. Chaturvedula A., Joshi D.P., Anderson C., Morris R., Sembrowich W.L., Banga A.K.- Dermal, subdermal, systemic concentrations of granisetron by iontophoretic delivery.- Pharm Res, 22, 1313-1319, 2005.
149. Rowland C.A., Chilcott R.P.- The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro.- J Control Release, 68, 157-166, 2000.
150. Vranken J.H., Dijkgraaf M.G., Kruis M.R., van Dasselaar N.T., van der Vegt M.H.- Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: a placebo-controlled trial.- Pain, 118, 224-231, 2005.
151. Pacini S., Punzi T., Gulisano M., Cecchi F., Vannucchi S., Ruggiero M. - Transdermal delivery of heparin using pulsed current iontophoresis.- Pharm Res, 23, 114-120, 2006.
152. Brand R.M., Hannah T.L., Hamel F.G.- A combination of iontophoresis and the chelating agent 1,10 phenanthroline act synergistically as penetration enhancers.- AAPS PharmSci, 2, E35, 2000.
153. Jain A., Ghosh B., Rajgor N., Desai B.G.- Passive and iontophoretic permeation of glipizide.- Eur J Pharm Biopharm, 69, 958-963, 2008.
154. Li S.K., Ghanem A.H., Teng C.L., Hardee G.E., Higuchi W.I. - Iontophoretic transport of oligonucleotides across human epidermal membrane: a study of the Nernst-Planck model.- J Pharm Sci, 90, 915-931, 2001.
155. Sakamoto T., Miyazaki E., Aramaki Y., Arima H., Takahashi M., Kato Y., Koga M., Tsuchiya S.- Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice.- Gene Ther, 11, 317-324, 2004.
156. Brand R.M., Hannah T.L., Norris J., Iversen P.L.- Transdermal delivery of antisense oligonucleotides can induce changes in gene expression in vivo.- Antisense Nucleic Acid Drug Dev, 11, 1-6, 2001.
157. Brus C., Santi P., Colombo P., Kissel T.- Distribution and quantification of polyethylenimine oligodeoxynucleotide complexes in human skin after iontophoretic delivery using confocal scanning laser microscopy.- J Control Release, 84, 171-181, 2002.
158. Fitters D.G., Bouwstra J.A.- Iontophoretic enhancement of timolol across human dermatomed skin in vitro.- J Drug Target, 12, 19-24, 2004.
159. Stagni G., O'Donnell D., Liu Y.J., Lay D.L., Morgan T., Shepherd A.M. - Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis.- J Control Release, 63, 331-339, 2000.
160. Kanikkannan N., Singh J., Ramarao R- In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species.- J Control Release, 71, 99-105, 2001.
161. Conjeevaram R., Chaturvedula A., Betageri G.V., Sunkara G., Banga A.K.- Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.- Pharm Res, 20, 1496-1501, 2003.
162. Tura A., Murein A., Pacini G.- Non-invasive glucose monitoring: assessment of technologies and devices according to quantitative criteria.- Diabetes Res Clin Pract, 77, 16-40, 2007.
163. Potts R.O., Tamada J.A., Tierney M.J.- Glucose monitoring by reverse iontophoresis.- Diabetes Metab Res Rev, 18, Suppl 1, S49-53, 2002.
164. Tierney M.J., Tamada J.A., Potts R.O., Jovanovic L., Garg S. - Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes.- Biosens Bioelectron, 16, 621-629, 2001.
165. Group T.D.R.i.C.N.S.- Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia.- Diabetes Care, 27, 722-726, 2004.
166. Pltzer K.R D.S., Dunn, T., Edelman S., Jayalakshmi Y., Kenendy J., Tamada J.A. Potts R.O.- Detection of hypoglycemia with the GlucoWatch Bopgrapher.- Diabetes Care, 24, 881-885, 2001.
167. Nunnold T., Colberg S.R., Herriott M.T., Somma C.T.- Use of the noninvasive GlucoWatch Biographer during exercise of varying intensity.- Diabetes Technol Ther, 6, 454-462, 2004.
168. Tamada J.A., Davis T.L., Leptien A.D., Lee J., Wang B., Lopatin M., Wei C., Wilson D., Comyns K., Eastman R.C.- The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2 Biographer.- Diabetes Technol Ther, 6, 357-367, 2004.
169. Tamada J.A., Comyns K.- Effect of formulation factors on electroosmotic glucose transport through human skin in vivo.- J Pharm Sci, 94, 1839-1849, 2005.
170. DiabetesNet.com- Animas GlucoWatch Update.- http://www.diabetesnet.com/ diabetes_technology/glucowatch.php
171. Rhee S.Y., Chon S., Koh G., Paeng J.R., Oh S., Woo J.T., Kim S.W., Kim J.W., Kim Y.S.- Clinical experience of an iontophoresis based glucose measuring system.- J Korean Med Sci, 22, 70-73, 2007.
172. Sieg A., Guy R.H., Delgado-Charro M.B.- Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo. - Pharm Res, 21, 1805-1810, 2004.
173. Sieg A., Guy R.H., Delgado-Charro M.B.- Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoring.- Biophys J, 87, 3344-3350, 2004.
174. Sieg A., Guy R.H., Delgado-Charro M.B.- Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept.- Clin Chem, 50, 1383-1390, 2004.
175. Sieg A., Guy R.H., Delgado-Charro M.B.- Reverse iontophoresis for noninvasive glucose monitoring: the internal standard concept.- J Pharm Sci, 92, 2295-2302, 2003.
176. Leboulanger B., Aubry J.M., Bondolfi G., Guy R.H., Delgado-Charro M.B. - Lithium monitoring by reverse iontophoresis in vivo.- Clin Chem, 50, 2091-2100, 2004.
177. Delgado-Charro M.B., Guy R.H.- Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring.- Pharm Res, 20, 1508-1513, 2003.
178. Nixon S., Sieg A., Delgado-Charro M.B., Guy R.H.- Reverse iontophoresis of L-lactate: in vitro and in vivo studies.- J Pharm Sci, 96, 3457-3465, 2007.
179. Leboulanger B., Fathi M., Guy R.H., Delgado-Charro M.B.- Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling.- Pharm Res, 21, 1214-1222, 2004.
180. Wascotte V., Leboulanger B., Guy R.H., Delgado-Charro M.B. - Reverse iontophoresis of lithium: electrode formulation using a thermoreversible polymer.- Eur J Pharm Biopharm, 59, 237-240, 2005.
181. Leboulanger B., Guy R.H., Delgado-Charro M.B.- Non-invasive monitoring of phenytoin by reverse iontophoresis.- Eur J Pharm Sci, 22, 427-433, 2004.
182. Wascotte V., Caspers P., de Sterke J., Jadoul M., Guy R.H., Preat V.- Assessment of the "skin reservoir" of urea by confocal Raman microspectroscopy and reverse iontophoresis in vivo.- Pharm Res, 24, 1897-1901, 2007.
183. Wascotte V., Delgado-Charro M.B., Rozet E., Wallemacq P., Hubert P., Guy R.H., Preat V.- Monitoring of urea and potassium by reverse iontophoresis in vitro.- Pharm Res, 24, 1131-1137, 2007.
184. Wascotte V., Rozet E., Salvaterra A., Hubert P., Jadoul M., Guy R.H., Preat V.- Non-invasive diagnosis and monitoring of chronic kidney disease by reverse iontophoresis of urea in vivo.- Eur J Pharm Biopharm, 2008.
185. Degim I.T., Ilbasmis S., Dundaroz R., Oguz Y.- Reverse iontophoresis: a non-invasive technique for measuring blood urea level.- Pediatr Nephrol, 18, 1032-1037, 2003.
186. Nicoli S., Santi R- Transdermal delivery of aminoglycosides: amikacin transport and iontophoretic non-invasive monitoring. - J Control Release, 111, 89-94, 2006.
187. Yan G., Higuchi W.I., Szabo A., Li S.K.- Correlation of transdermal iontophoretic phenylalanine and mannitol transport: test of the internal standard concept under DC iontophoresis and constant resistance AC iontophoresis conditions.- J Control Release, 98, 127-138, 2004.
188. Longo N., Li S.K., Yan G., Kochambilli R.P., Papangkorn K., Berglund D., Ghanem A.H., Ashurst C.L., Ernst S.L., Pasquali M., Higuchi W.I.- Noninvasive measurement of phenylalanine by iontophoretic extraction in patients with phenylketonuria.- J Inherit Metab Dis, 30, 910-915, 2007.
189. Sieg A., Jeanneret F., Fathi M., Hochstrasser D., Rudaz S., Veuthey J.L., Guy R.H., Delgado-Charro M.B.- Extraction of amino acids by reverse iontophoresis: Simulation of therapeutic monitoring in vitro.- Eur J Pharm Biopharm, 2008.
190. Sekkat N., Naik A., Kalia Y.N., Glikfeld P., Guy R.H.- Reverse iontophoretic monitoring in premature neonates: feasibility and potential.- J Control Release, 81, 83-89, 2002.
191. J.C.K.G.B.a.K.- Application of the electrodiffusion theory for a homogenous membrane to iontophoretic transport through skin.- J. Control Release, 8, 195-210, 1989.
192. Mudry B., Guy R.H., Delgado-Charro M.B.-Transport numbers in transdermal iontophoresis.- Biophys J, 90, 2822-2830, 2006.
193. Mudry B., Guy R.H., Delgado-Charro M.B.- Electromigration of ions across the skin: determination and prediction of transport numbers.- J Pharm Sci, 95, 561-569, 2006.
194. Marro D., Kalia Y.N., Delgado-Charro M.B., Guy R.H.- Contributions of electromigration and electroosmosis to iontophoretic drug delivery.- Pharm Res, 18, 1701-1708, 2001.
195. Mudry B., Carrupt RA., Guy R.H., Delgado-Charro M.B.- Quantitative structure-permeation relationship for iontophoretic transport across the skin.- J Control Release, 122, 165-172, 2007.
196. Mudry B., Guy R.H., Delgado-Charro M.B.- Prediction of iontophoretic transport across the skin.- J Control Release, 111, 362-367, 2006.
197. Gyory J.R and Phipps J.B.- Transdermal ion migration.- Adv Drug Del Rev, 9, 137-176, 1992.
198. Marro D., Kalia Y. N., Delgado-Charro M.B., Guy R.H.- Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.- Pharm Res, 18, 1709-1713, 2001.
199. Abla N., Geiser L., Mirgaldi M., Naik A., Veuthey J.L., Guy R.H., Kalia Y.N.- Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility. -J Pharm Sci, 94, 2667-2675, 2005.
200. Tashiro Y., Shichibe S., Kato Y., Hayakawa E., Itoh K.- Effect of lipophilicity on in vivo iontophoretic delivery. I. NSAIDs.- Biol Pharm Bull, 24, 278-283, 2001.
201. Tashiro Y., Sami M., Shichibe S., Kato Y., Hayakawa E., Itoh K.- Effect of lipophilicity on in vivo iontophoretic delivery. II. Beta-blockers.- Biol Pharm Bull, 24, 671-677, 2001.
202. Marro D., Guy R.H., Delgado-Charro M.B.- Characterization of the iontophoretic permselectivity properties of human and pig skin.- J Control Release, 70, 213-217, 2001.
203. Nicoli S., Cappellazzi M., Colombo P., Santi P.- Characterization of the permselective properties of rabbit skin during transdermal iontophoresis.- J Pharm Sci, 92, 1482-1488, 2003.
204. Bath B.D., White H.S., Scott E.R.- Visualization and analysis of electroosmotic flow in hairless mouse skin.- Pharm Res, 17, 471-475, 2000.
205. Guy R.H., Kalia Y.N., Delgado-Charro M.B., Merino V., Lopez A., Marro D.- Iontophoresis: electrorepulsion and electroosmosis. - J Control Release, 64, 129-132, 2000.
206. Bath B.D., Scott E.R., Phipps J.B., White H.S.- Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration, electroosmosis to transport in hair follicles.- J Pharm Sci, 89, 1537-1549, 2000.
207. Curdy C., Kalia Y.N., Falson-Rieg F., Guy R.H.- Recovery of human skin impedance in vivo after iontophoresis: effect of metal ions.- AAPS PharmSci, 2, E23, 2000.
208. Curdy C., Kalia Y.N., Guy R.H.- Post-iontophoresis recovery of human skin impedance in vivo.- Eur J Pharm Biopharm, 53, 15-21, 2002.
209. Curdy C., Kalia Y.N., Guy R.H.- Non-invasive assessment of the effects of iontophoresis on human skin in-vivo.- J Pharm Pharmacol, 53, 769-777, 2001.
210. Singh J., Gross M., Sage B., Davis H.T., Maibach H.I.- Regional variations in skin barrier function and cutaneous irritation due to iontophoresis in human subjects.- Food Chem Toxicol, 39, 1079-1086, 2001.
211. Singh J., Gross M., Sage B., Davis H.T., Maibach H.I.- Effect of saline iontophoresis on skin barrier function and cutaneous irritation in four ethnic groups.- Food Chem Toxicol, 38, 717-726, 2000.
212. Kanebako M., Inagi T., Takayama K.- Evaluation of skin barrier function using direct current I: effects of conductivity, voltage, distance between electrodes and electrode area.- Biol Pharm Bull, 25, 1456-1460, 2002.
213. Kanebako M., Inagi T., Takayama K.- Evaluation of skin barrier function using direct current II: effects of duty cycle, waveform, frequency and mode.- Biol Pharm Bull, 25, 1623-1628, 2002.
214. Kanebako M., Inagi T., Takayama K.- Evaluation of skin barrier function using direct current III: effects of electrode distance, boundary length and shape.- Biol Pharm Bull, 26, 518-522, 2003.
215. Fatouros D.G., Groenink H.W., de Graaff A.M., van Aelst A.C., Koerten H.K., Bouwstra J.A.- Visualization studies of human skin in vitro/in vivo under the influence of an electrical field.- Eur J Pharm Sci, 29, 160-170, 2006.
216. Pechtold L.A., Bodde H.E., Junginger H.E., Koerten H.K., Bouwstra J.A.- X-ray microanalysis of cryopreserved human skin to study the effect of iontophoresis on percutaneous ion transport.- Pharm Res, 18, 1012-1017, 2001.
217. Denda M., Kumazawa N.- Negative electric potential induces alteration of ion gradient and lamellar body secretion in the epidermis, accelerates skin barrier recovery after barrier disruption. - J Invest Dermatol, 118, 65-72, 2002.
218. Lee S.H., Choi E.H., Feingold K.R., Jiang S., Ahn S.K.- Iontophoresis itself on hairless mouse skin induces the loss of the epidermal calcium gradient without skin barrier impairment.- J Invest Dermatol, 111, 39-43, 1998.
219. Choi E.H., Kim M.J., Yeh B.I., Ahn S.K., Lee S.H.- Iontophoresis and sonophoresis stimulate epidermal cytokine expression at energies that do not provoke a barrier abnormality: lamellar body secretion and cytokine expression are linked to altered epidermal calcium levels.- J Invest Dermatol, 121, 1138-1144, 2003.
220. Sekkat N., Kalia Y.N., Guy R.H.- Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates.- Pharm Res, 21, 1390-1397, 2004.